FDA Approved: DASATINIB — Supplemental Application (Apotex Corp.)

View source ↗

Summary

The FDA approved Apotex Corp.'s supplemental application for dasatinib (DASATINIB).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia
• Chronic Myeloid Leukemia

Drugs mentioned

• DASATINIB (Dasatinib)

Snippet

SUPPL AP for DASATINIB (DASATINIB)